Cholangiocarcinoma (CCA) includes a cluster of highly heterogeneous biliary malignant
tumours that can arise at any point of the biliary tree. Their incidence is increasing globally …

Cholangiocarcinoma (CCA) is a highly lethal adenocarcinoma of the hepatobiliary system,
which can be classified as intrahepatic, perihilar and distal. Each anatomic subtype has …

Cholangiocarcinoma is a devastating malignancy that presents late, is notoriously difficult to
diagnose, and is associated with a high mortality. The incidence of intrahepatic …

Cholangiocarcinoma (CCA) comprises a heterogeneous group of cancers with pathologic
features of biliary tract differentiation, and is presumed to arise from the intra-or extrahepatic …

Cholangiocarcinoma is a disease entity comprising diverse epithelial tumours with features
of cholangiocyte differentiation: cholangiocarcinomas are categorized according to …

Hepatocellular carcinoma (HCC) is the commonest primary malignant cancer of the liver in
the world. Given that the burden of chronic liver disease is expected to rise owing to …

2.0 BACKGROUND Mortality rates from intrahepatic cholangiocarcinoma have risen steeply
and steadily over the past 30 years and since the mid 1990s more deaths have been coded …

The British Society of Gastroenterology guidelines on the management of
cholangiocarcinoma were originally published in 2002. This is the first update since then …

Background/Aims: The age-standardized mortality rate for hepatocellular carcinoma is
increasing in several countries. However, in England and Wales we previously reported an …

Biliary tract cancer (BTC), comprising< 1% of all human cancers and∼ 10%–15% of all
primary liver cancers, presents mostly in the seventh decade with a small male …